The human microbiome: Opportunities and challenges for clinical care

Internal Medicine Journal

Volumn 45, Issue 9, 2015, Pages 889-898

  Rogers, G B ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Dysbiosis; Infection; Microbiota

Indexed keywords

ANTIMICROBIAL THERAPY; BACTERIAL GROWTH; DYSBIOSIS; GENE SEQUENCE; HUMAN; INFECTION; MICROBIOME; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; ADAPTIVE IMMUNITY; COMPLICATION; DRUG EFFECTS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; METAGENOMICS; TRENDS;

ANTIINFECTIVE AGENT;

ADAPTIVE IMMUNITY; ANTI-INFECTIVE AGENTS; DYSBIOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; METAGENOMICS; MICROBIOTA;

EID: 84940568593     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12650     Document Type: Review

References (95)

1. Tlaskalova-Hogenova H, Tuckova L, Mestecky J, Kolinska J, Rossmann P, Stepankova R etal. Interaction of mucosal microbiota with the innate immune system. Scand J Immunol 2005; 62(Suppl 1): 106-113.
2. O'Toole PW, Claesson MJ. Gut microbiota: changes throughout the lifespan from infancy to elderly. Int Dairy J 2010; 20: 281-291.
3. Biagi E, Candela M, Fairweather-Tait S, Franceschi C, Brigidi P. Aging of the human metaorganism: the microbial counterpart. Age (Omaha) 2012; 34: 247-267.
4. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J etal. Is meconium from healthy newborns actually sterile? Res Microbiol 2008; 159: 187-193.
5. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N etal. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107: 11971-11975.
6. Martin R, Heilig HG, Zoetendal EG, Jimenez E, Fernandez L, Smidt H etal. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res Microbiol 2007; 158: 31-37.
7. Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C etal. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 2014; 63: 559-566.
8. Slezak K, Krupova Z, Rabot S, Loh G, Levenez F, Descamps A etal. Association of germ-free mice with a simplified human intestinal microbiota results in a shortened intestine. Gut Microbes 2014; 5: 176-182.
9. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A etal. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108: 3047-3052.
10. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M etal. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227.
11. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM etal. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012; 56: 5811-5820.
12. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA etal. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108.
13. Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH etal. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 2013; 51: 2884-2892.
14. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
15. Stearns JC, Lynch MD, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG etal. Bacterial biogeography of the human digestive tract. Sci Rep 2011; 1: 170.
16. Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, Hudcovic T, Vannucci L, Tučková L etal. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011; 8: 110-120.
17. Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 2014; 146: 1449-1458.
18. Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM etal. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12: 611-622.
19. Schommer NN, Gallo RL. Structure and function of the human skin microbiome. Trends Microbiol 2013; 21: 660-668.
20. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC etal. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324: 1190-1192.
21. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T etal. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006; 72: 1027-1033.
22. Lan Y, Kriete A, Rosen G. Selecting age-related functional characteristics in the human gut microbiome. Microbiome 2013; 1: 2.
23. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E etal. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011; 108(Suppl 1): 4586-4591.
24. Whelan FJ, Verschoor CP, Stearns JC, Rossi L, Luinstra K, Loeb M etal. The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann Am Thorac Soc 2014; 11: 513-521.
25. Pechal JL, Crippen TL, Benbow ME, Tarone AM, Dowd S, Tomberlin JK. The potential use of bacterial community succession in forensics as described by high throughput metagenomic sequencing. Int J Legal Med 2014; 128: 193-205.
26. Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol 2013; 16: 246-254.
27. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H etal. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 2008; 105: 2117-2122.
28. Sommer F, Bäckhed F. The gut microbiota - masters of host development and physiology. Nat Rev Microbiol 2013; 11: 227-238.
29. Delzenne NM, Neyrinck AM, Cani PD. Gut microbiota and metabolic disorders: how prebiotic can work? Br J Nutr 2013; 109(Suppl 2): S81-85.
30. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D etal. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282-1286.
31. Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR etal. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 2012; 7: e35240.
32. Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis 2012; 23: 19260.
33. Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TM, Comelli EM. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes 2014; 4: e121.
34. Kamada N, Núñez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014; 146: 1477-1488.
35. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809.
36. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-433.
37. Yan AW, Schnabl B. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 2012; 4: 110-118.
38. Fiehn NE, Gutschik E, Larsen T, Bangsborg JM. Identity of streptococcal blood isolates and oral isolates from two patients with infective endocarditis. J Clin Microbiol 1995; 33: 1399-1401.
39. Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006; 33: 401-407.
40. Reid DW, Anderson GJ, Lamont IL. Role of lung iron in determining the bacterial and host struggle in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2009; 297: 795-802.
41. Decelle L, Thys F, Zech F, Verschuren F. Ventilation-associated pneumonia after intubation in the prehospital or the emergency unit. Eur J Emerg Med 2013; 20: 61-63.
42. Mietto C, Pinciroli R, Patel N, Berra L. Ventilator associated pneumonia: evolving definitions and preventive strategies. Respir Care 2013; 58: 990-1007.
43. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
44. Rogers GB, Carroll MP, Zain NM, Bruce KD, Lock K, Walker W etal. Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia. J Clin Microbiol 2013; 51: 4029-4035.
45. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004; 42: 5176-5183.
46. Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML etal. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 2013; 68: 731-737.
47. Rogers GB, Carroll MP, Hoffman LR, Walker AW, Fine DA, Bruce KD. Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes 2010; 1: 85-93.
48. Rogers GB, Hoffman LR, Döring G. Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis. J Cyst Fibros 2011; 10: 387-400.
49. Stressmann FA, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, Carroll MP etal. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012; 67: 867-873.
50. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM etal. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS ONE 2012; 7: e45001.
51. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR etal. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 2008; 4: e1000184.
52. Wang BY, Kuramitsu HK. Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii. Appl Environ Microbiol 2005; 71: 354-362.
53. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6: e280.
54. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut 2004; 53: 1-4.
55. Nickerson KP, McDonald C. Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS ONE 2012; 7: e52132.
56. Savage DC. Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 1977; 31: 107-133.
57. Parnell JA, Reimer RA. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 2012; 3: 29-34.
58. Nugent JL, McCoy AN, Addamo CJ, Jia W, Sandler RS, Keku TO. Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J Proteome Res 2014; 13: 1921-1929.
59. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. Bacterial vaginosis: a public health review. BJOG 2001; 108: 439-450.
60. Eschenbach DA. Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin Infect Dis 1993; 16: S282-287.
61. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infections and prematurity and the role of preventive strategies. Semin Neonatol 2002; 7: 259-274.
62. Sharma H, Tal R, Clark NA, Segars JH. Microbiota and pelvic inflammatory disease. Semin Reprod Med 2014; 32: 43-49.
63. Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J etal. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010; 202: 1907-1915.
64. Loux HR, Coplin WML. Chronic phagedaena due to mixed infection. Ann Surg 1902; 35: 586-597.
65. Rogers GB, Daniels TW, Tuck A, Carroll MP, Connett GJ, David GJ etal. Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches. BMC Pulm Med 2009; 9: 14.
66. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987; 155: 335-350.
67. Lane DJ, Pace B, Olsen GJ, Stahl DA, Sogin ML, Pace NR. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc Natl Acad Sci U S A 1985; 82: 6955-6959.
68. Sboner A, Mu XJ, Greenbaum D, Auerbach RK, Gerstein MB. The real cost of sequencing: higher than you think! Genome Biol 2011; 12: 125.
69. Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012; 486: 215-221.
70. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C etal. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
71. Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M etal. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res 2013; 41: e1.
72. Rogers GB, Bruce KD. Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application. Mol Diagn Ther 2010; 14: 343-350.
73. Rogers GB, Shaw D, Marsh RL, Carroll MP, Serisier DJ, Bruce KD. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax 2015; 70: 74-81.
74. Tyler AD, Smith MI, Silverberg MS. Analyzing the human microbiome: a 'how to' guide for physicians. Am J Gastroenterol 2014; 109: 983-993.
75. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR etal. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
76. Greer RL, Morgun A, Shulzhenko N. Bridging immunity and lipid metabolism by gut microbiota. J Allergy Clin Immunol 2013; 132: 253-262.
77. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 2013; 21: 167-173.
78. Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol 2012; 9: 565-576.
79. Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87: 534-538.
80. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS ONE 2013; 8: e53653.
81. Kumar PS, Griffen AL, Moeschberger ML, Leys EJ. Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin Microbiol 2005; 43: 3944-3955.
82. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect 2012; 18: 21-27.
83. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C etal. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008; 76: 4726-4736.
84. Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O'Leary CE etal. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014; 20: 524-530.
85. Dardas M, Gill SR, Grier A, Pryhuber GS, Gill AL, Lee YH etal. The impact of postnatal antibiotics on the preterm intestinal microbiome. Pediatr Res 2014; 76: 150-158.
86. Duytschaever G, Huys G, Bekaert M, Boulanger L, De Boeck K, Vandamme P. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. J Cyst Fibros 2013; 12: 206-215.
87. Lynch SV, Goldfarb KC, Wild YK, Kong W, De Lisle RC, Brodie EL. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota. Gut Microbes 2013; 4: 41-47.
88. Ranganathan SC, Parsons F, Gangell C, Brennan S, Stick SM, Sly PD; Australian Respiratory Early Surveillance Team for Cystic Fibrosis. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax 2011; 66: 408-413.
89. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583-591.
90. Montassier E, Batard E, Massart S, Gastinne T, Carton T, Caillon J etal. 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. Microb Ecol 2014; 67: 690-699.
91. Myles IA, Pincus NB, Fontecilla NM, Datta SK. Effects of parental omega-3 fatty acid intake on offspring microbiome and immunity. PLoS ONE 2014; 9: e87181.
92. Engelbrektson A, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G etal. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 2009; 58: 663-670.
93. Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C etal. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE 2012; 7: e49138.
94. Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM etal. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A 2014; 111: E2329-2338.
95. Huang S, Li R, Zeng X, He T, Zhao H, Chang A etal. Predictive modeling of gingivitis severity and susceptibility via oral microbiota. ISME J 2014; 8: 1768-1780.